Current Atherosclerosis Reports

Scope & Guideline

Connecting research to clinical practice in cardiology.

Introduction

Delve into the academic richness of Current Atherosclerosis Reports with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1523-3804
PublisherCURRENT MEDICINE GROUP
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1999 to 2024
AbbreviationCURR ATHEROSCLER REP / Curr. Atheroscleros. Rep.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106

Aims and Scopes

Current Atherosclerosis Reports serves as a pivotal platform for disseminating research focused on the pathophysiology, prevention, and treatment of atherosclerosis and related cardiovascular diseases. The journal emphasizes multidisciplinary approaches, integrating clinical, epidemiological, and basic research perspectives.
  1. Atherosclerosis Mechanisms and Pathophysiology:
    Research exploring the underlying biological and molecular mechanisms of atherosclerosis, including inflammation, lipid metabolism, and vascular biology.
  2. Clinical Management and Therapeutics:
    Focused studies on various treatment modalities for atherosclerosis, including pharmacotherapy, lifestyle interventions, and novel therapeutic approaches such as gene editing and monoclonal antibodies.
  3. Epidemiology and Risk Factors:
    Investigations into the epidemiology of cardiovascular diseases, identifying risk factors such as genetics, lifestyle, and social determinants of health.
  4. Pediatric and Adolescent Cardiovascular Health:
    Research dedicated to understanding and managing cardiovascular risks in younger populations, including familial hypercholesterolemia and dyslipidemia.
  5. Emerging Technologies in Cardiovascular Research:
    Utilization of advanced technologies such as artificial intelligence, machine learning, and digital health innovations to enhance cardiovascular disease prevention and management.
  6. Nutritional and Behavioral Interventions:
    Studies that examine the impact of diet, nutrition, and behavioral changes on cardiovascular health, emphasizing the importance of community-based approaches.
Current Atherosclerosis Reports is witnessing an exciting evolution in its focus areas, with several emerging themes gaining prominence. These trends highlight the journal's responsiveness to contemporary challenges in cardiovascular health.
  1. Digital Health and Artificial Intelligence:
    Recent publications emphasize the integration of digital health technologies and artificial intelligence in cardiovascular disease prevention and management, reflecting a modern approach to patient care.
  2. Social Determinants of Health:
    An increasing number of studies address the impact of social determinants on cardiovascular health, underscoring the need for equitable healthcare solutions and community interventions.
  3. Personalized Medicine and Genomics:
    Emerging themes in personalized medicine, including the application of genetic testing and polygenic risk scores, are gaining traction as researchers seek to tailor treatments based on individual risk profiles.
  4. Gut Microbiome and Cardiovascular Disease:
    There is a growing interest in the relationship between the gut microbiome and cardiovascular health, exploring how microbial factors may influence atherosclerosis and metabolic disorders.
  5. Mental Health and Cardiovascular Outcomes:
    Research linking mental health conditions, such as depression and anxiety, with cardiovascular disease risk is becoming more prevalent, highlighting the importance of holistic approaches to patient care.

Declining or Waning

As the landscape of cardiovascular research evolves, certain themes within Current Atherosclerosis Reports appear to be losing traction. This decline may reflect shifts in research focus or advancements in the field that render previous areas less prominent.
  1. Traditional Lipid Management Strategies:
    There is a noticeable decrease in papers focusing solely on traditional lipid management strategies, such as statins, as newer therapies and comprehensive approaches gain importance.
  2. Basic Science Studies without Clinical Relevance:
    Research that lacks direct clinical applications or relevance to patient care is becoming less frequent, signaling a shift towards studies that bridge laboratory findings with real-world outcomes.
  3. Single Risk Factor Studies:
    Research concentrating on isolated cardiovascular risk factors is declining, with a growing emphasis on multifactorial approaches that consider the complex interplay of various risk elements.
  4. Purely Genetic Studies:
    While genetics remains a vital area of research, there is a waning interest in studies that do not integrate genetic findings with clinical implications or broader epidemiological perspectives.

Similar Journals

Cardiology Journal

Empowering global research in cardiology.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

CARDIOLOGY

Exploring the forefront of heart and vascular research.
Publisher: KARGERISSN: 0008-6312Frequency: 6 issues/year

CARDIOLOGY, published by KARGER, is a renowned scholarly journal dedicated to the advancement of research in the fields of cardiology and cardiovascular medicine. Since its inception in 1937, the journal has consistently provided a platform for high-quality, peer-reviewed articles that contribute to the understanding and treatment of heart and vascular diseases. With an impressive convergence through 2024, CARDIOLOGY holds a respectable Q2 ranking in both the Cardiology and Cardiovascular Medicine and Pharmacology (medical) categories, placing it within the 53rd and 45th percentiles of respective Scopus ranks. Based in Switzerland, the journal serves as an essential resource for researchers and practitioners aiming to stay abreast of cutting-edge developments and evidence-based practices in cardiovascular health. While it currently does not offer open access options, its commitment to rigorous scientific standards solidifies its significance within the academic community. We invite readers to explore the latest research findings and contribute to this vital field through publications in CARDIOLOGY.

JACC-Basic to Translational Science

Elevating Cardiovascular Science for a Healthier Tomorrow
Publisher: ELSEVIER SCIENCE INCISSN: 2452-302XFrequency: 12 issues/year

JACC-Basic to Translational Science, published by Elsevier Science Inc, is a distinguished open access journal that has been advancing the field of cardiology and cardiovascular medicine since its inception in 2016. With an ISSN of 2452-302X and an impressive Q1 ranking in Cardiology and Cardiovascular Medicine as per the 2023 category quartiles, the journal is recognized for its commitment to publishing high-quality research that bridges the gap between basic science and clinical application. Operating from its base in the United States, JACC-Basic to Translational Science is at the forefront of enriching the academic community and healthcare professionals with cutting-edge studies and insights. The journal's robust reach is highlighted by its rank of #14 out of 387 in Scopus for its pertinent subject area, placing it in the 96th percentile. It aims to provide an open access platform that fosters collaboration and the exchange of ideas to ensure the continuous advancement of cardiovascular research. Readers can easily access the latest findings and contribute to the ever-evolving landscape of cardiology through this esteemed publication.

Acta Angiologica

Bridging Knowledge Gaps in Angiology
Publisher: VIA MEDICAISSN: 1234-950XFrequency: 4 issues/year

Acta Angiologica, published by VIA MEDICA, is an Open Access journal dedicated to the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1995, this esteemed journal has provided a vital platform for the dissemination of cutting-edge research and innovative medical practices, especially pertinent to vascular health. Being indexed in Scopus, it holds a rank of #352 out of 387 in its category for 2023, positioning it in the 9th percentile among contemporaneous journals. The journal's commitment to scholarly excellence and accessibility is underscored by its embrace of open access publishing, allowing researchers, professionals, and students to engage with vital advancements in the field without financial barriers. With a converged timeline from 2005 to 2024, Acta Angiologica continues to play a crucial role in bridging gaps in cardiovascular knowledge, fostering collaboration across disciplines, and advancing the implementation of preventative and therapeutic strategies in vascular medicine. Located in Gdansk, Poland, the journal is poised to make significant contributions to the cardiovascular research landscape.

Anatolian Journal of Cardiology

Connecting Global Hearts with Cutting-edge Cardiovascular Knowledge.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Journal of Atherosclerosis and Thrombosis

Elevating the standards of cardiovascular research and discovery.
Publisher: JAPAN ATHEROSCLEROSIS SOCISSN: 1340-3478Frequency: 12 issues/year

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

CIRCULATION

Advancing Cardiovascular Insights, One Beat at a Time.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

CIRCULATION JOURNAL

Connecting Global Insights in Cardiology and Medicine.
Publisher: JAPANESE CIRCULATION SOCISSN: 1346-9843Frequency: 12 issues/year

CIRCULATION JOURNAL, published by the Japanese Circulation Society, stands as a premier platform for cutting-edge research in the fields of Cardiology and Cardiovascular Medicine. With an impressive impact factor placing it in the Q1 quartile for both cardiology and general medicine, this journal is essential for researchers and practitioners seeking to stay at the forefront of cardiovascular science. The journal's accessible open access options ensure that groundbreaking studies are widely disseminated, reflecting its commitment to advancing medical knowledge and improving patient care. Since its inception in 1996, CIRCULATION JOURNAL has fostered a global dialogue on vital cardiovascular issues, making it a vital resource for academics, healthcare professionals, and students alike. With its base in Tokyo, Japan, the journal not only highlights regional advancements but also contributes significantly to the global medical community.

Journal of Clinical Lipidology

Advancing lipid science for healthier hearts.
Publisher: ELSEVIER SCIENCE INCISSN: 1933-2874Frequency: 6 issues/year

Journal of Clinical Lipidology, published by Elsevier Science Inc, is a leading platform dedicated to advancing the understanding of lipidology and its impact on cardiovascular health. With an ISSN of 1933-2874 and E-ISSN 1876-4789, this esteemed journal boasts a remarkable Q1 ranking in key medical categories, including Cardiology and Cardiovascular Medicine, Internal Medicine, and Nutrition and Dietetics, solidifying its position as a vital resource for the latest research and clinical practices. This journal not only serves as a repository for groundbreaking studies but also provides insights into complex interactions between lipid metabolism and chronic diseases, including diabetes and obesity. Researchers, practitioners, and students will find a wealth of carefully vetted articles that drive innovation and improve patient outcomes in lipid management. Although it does not currently offer open access, the Journal of Clinical Lipidology ensures high visibility through rigorous peer review and a commitment to quality, making it an essential read for anyone invested in the future of lipidology.

HEART AND VESSELS

Fostering Knowledge for a Stronger Cardiovascular Future
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.